Page 80 - Sohini Das

SII, Bharat Biotech to get bulk of Rs 15K-crore profit pool: Report

At present, SII sells its vaccine Covishield to the Centre for Rs 150 per dose, to state governments for Rs 300 and to private hospitals for Rs 600.

Covid-19 crisis: Over no response, states relax global vaccine tender norms

BMC was the first civic body in the country to float a global tender for purchasing vaccines

Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests

Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero

May start vaccine exports by year end, India remains priority: Serum

Company says it never exported vaccines at the cost of the people of India

Covid-19 crisis: Pharma majors step up support to affected employees

A company spokesperson said this benefit will be over and above the existing group term insurance

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech

Vaccine effective against all emerging coronavirus variants, says study

Cipla open to forge a partnership to distribute Covid-19 vaccines in India

The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)

Covid-19: Dr Reddy's rolls out Sputnik V in India at Rs 995 per dose

The imported doses of the vaccine are priced at a maximum retail price of Rs 948 plus 5 percent GST per dose, with the possibility of a lower price point when local supply begins, says DRL

2 billion Covid-19 doses a long haul, but most will be covered by December

SII aims to make 50 million doses of Covovax (the Novavax vaccine) per month at its Pune plant

India's vaccine supplies to improve as it braces for Covid-19 third wave

India has vaccinated 37.2 million people with both doses of a vaccine, and about 135.5 million have received at least the first jab

Lupin willing to take partners to bring mRNA Covid-19 vaccines to India

Executive says company is looking for tie-ups to bring in drugs like Remdesivir

Bharat Biotech trial nod a turning point for paediatric Covid-19 vaccine

Bharat Biotech has already conducted trials on children 12 years and above

FabiFlu numero uno in Indian pharma market, show April sales data

With sales of Rs 352 crore in April, this brand alone accounted for over 2 per cent of the total domestic pharma market sales of Rs 15,662 crore

Russia's Sputnik V jabs set to make India debut at private hospitals

A large vaccine consignment is expected from Russia by third week of this month

Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines

Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import

India's pharma market rebounds in April, clocks 51.5% sales growth

Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth

Access to foreign Covid-19 vaccine a long haul, say Indian companies

US pharmaceutical associations feel that the decision to support the patent waiver would weaken already-strained supply chains

Hospitals to reap the benefits of RBI's health care liquidity injection

While top hospital chains reported an average borrowing cost of 9.8% in H1FY21, loans under the special RBI liquidity window for the health care sector are expected to come at around 6%

RBI's Covid relief: Good move, but late, says health care industry

While some companies said they were open to borrowing, others felt their working capital cycle was comfortable

Hetero recalls a batch of its remdesivir brand Covifor after side effects

Some patients in Raigad district of Maharashtra developed side effects like fever and chills